235 related articles for article (PubMed ID: 23053769)
1. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial.
Baharivand N; Mahdavifard A; Fouladi RF
Int Ophthalmol; 2013 Feb; 33(1):39-46. PubMed ID: 23053769
[TBL] [Abstract][Full Text] [Related]
2. Atypical toxoplasmic retinochoroiditis.
Theodoropoulou S; Schmoll C; Templeton K; Dhillon B
BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22669878
[TBL] [Abstract][Full Text] [Related]
3. Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone.
Zamora YF; Arantes T; Reis FA; Garcia CR; Saraceno JJ; Belfort R; Muccioli C
Arq Bras Oftalmol; 2015; 78(4):216-9. PubMed ID: 26375334
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis.
Kishore K; Conway MD; Peyman GA
Ophthalmic Surg Lasers; 2001; 32(3):183-92. PubMed ID: 11371084
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.
Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF
Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis.
Souza CE; Nascimento H; Lima A; Muccioli C; Belfort R
Ocul Immunol Inflamm; 2018; 26(7):1041-1044. PubMed ID: 28448726
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal clindamycin for toxoplasmic retinochoroiditis.
Sobrin L; Kump LI; Foster CS
Retina; 2007 Sep; 27(7):952-7. PubMed ID: 17891023
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.
Soheilian M; Ramezani A; Azimzadeh A; Sadoughi MM; Dehghan MH; Shahghadami R; Yaseri M; Peyman GA
Ophthalmology; 2011 Jan; 118(1):134-41. PubMed ID: 20708269
[TBL] [Abstract][Full Text] [Related]
9. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
Colin J; Harie JC
J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
[TBL] [Abstract][Full Text] [Related]
10. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent toxoplasmic retinochoroiditis after clindamycin treatment].
Benzina Z; Chaabouni S; Hentati N; Trigui A; Chaabouni F; Ben Salah S; Khlif H; Feki J
J Fr Ophtalmol; 2005 Nov; 28(9):958-64. PubMed ID: 16395222
[TBL] [Abstract][Full Text] [Related]
12. Recurrent toxoplasmic retinochoroiditis after clindamycin: a case report.
Murphy GE
Ann Ophthalmol; 1982 Jul; 14(7):632-3. PubMed ID: 7125453
[No Abstract] [Full Text] [Related]
13. [Interest in treatment with subconjunctival clindamycin in toxoplasmic retinochoroiditis].
Ben Zina Z; Abid D; Kharrat W; Chaker N; Aloulou K; Chaâbouni M
Tunis Med; 2001 Mar; 79(3):157-60. PubMed ID: 11471444
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
15. Posterior segment findings by spectral-domain optical coherence tomography and clinical associations in active toxoplasmic retinochoroiditis.
Oliver GF; Ferreira LB; Vieira BR; Arruda S; Araújo M; Carr JM; Smith JR; Furtado JM
Sci Rep; 2022 Jan; 12(1):1156. PubMed ID: 35064148
[TBL] [Abstract][Full Text] [Related]
16. The role of intravitreal trimethoprim/sulfamethoxazole in the treatment of toxoplasma retinochoroiditis.
Choudhury H; Jindal A; Pathengay A; Bawdekar A; Albini T; Flynn HW
Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):137-40. PubMed ID: 25559528
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.
Stanford MR; See SE; Jones LV; Gilbert RE
Ophthalmology; 2003 May; 110(5):926-31; quiz 931-2. PubMed ID: 12750091
[TBL] [Abstract][Full Text] [Related]
18. Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis.
Fernandes Felix JP; Cavalcanti Lira RP; Grupenmacher AT; Assis Filho HLG; Cosimo AB; Nascimento MA; Leite Arieta CE
Am J Ophthalmol; 2020 May; 213():195-202. PubMed ID: 31926883
[TBL] [Abstract][Full Text] [Related]
19. Scleritis associated with toxoplasmic retinochoroiditis.
Rudich DS; Bhatnagar P
Arch Ophthalmol; 2012 May; 130(5):659-60. PubMed ID: 22652859
[No Abstract] [Full Text] [Related]
20. Clindamycin in the treatment of toxoplasmic retinochoroiditis.
Lakhanpal V; Schocket SS; Nirankari VS
Am J Ophthalmol; 1983 May; 95(5):605-13. PubMed ID: 6846454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
